OneTwenty is a Zurich-based startup at the vanguard of diabetes technology. With a mission to elevate diabetes care, the company specializes in developing AI-driven algorithms that enhance the functionality of diabetes devices. OneTwenty's proprietary technology stands as the first in the market capable of navigating the intricacies of human metabolism, offering an autonomous and streamlined approach to diabetes management.

Founded by Michael Rottmann and Dr. med. Julian M. Stiels // Investment in December 2023

Michael Rottmann

Latest news


DvH Ventures backs MedTech OneTwenty to revolutionize diabetes care


Let’s talk about it.

Submit your pitch deck here and join our newsletter to receive the latest updates and news about Dieter von Holtzbrinck Ventures.

start your pitch
Dieter von Holtzbrinck Ventures GmbH
Phone+49 221 933 161 0
connect with us on